242 related articles for article (PubMed ID: 34172930)
1. A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma.
Maiques O; Fanshawe B; Crosas-Molist E; Rodriguez-Hernandez I; Volpe A; Cantelli G; Boehme L; Orgaz JL; Mardakheh FK; Sanz-Moreno V; Fruhwirth GO
Br J Cancer; 2021 Aug; 125(5):699-713. PubMed ID: 34172930
[TBL] [Abstract][Full Text] [Related]
2. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
[TBL] [Abstract][Full Text] [Related]
3. Rho kinase inhibitors block melanoma cell migration and inhibit metastasis.
Sadok A; McCarthy A; Caldwell J; Collins I; Garrett MD; Yeo M; Hooper S; Sahai E; Kuemper S; Mardakheh FK; Marshall CJ
Cancer Res; 2015 Jun; 75(11):2272-84. PubMed ID: 25840982
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
He M; Cheng Y; Li W; Liu Q; Liu J; Huang J; Fu X
BMC Cancer; 2010 Apr; 10():170. PubMed ID: 20429915
[TBL] [Abstract][Full Text] [Related]
5. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway.
Kidera Y; Tsubaki M; Yamazoe Y; Shoji K; Nakamura H; Ogaki M; Satou T; Itoh T; Isozaki M; Kaneko J; Tanimori Y; Yanae M; Nishida S
J Exp Clin Cancer Res; 2010 Sep; 29(1):127. PubMed ID: 20843370
[TBL] [Abstract][Full Text] [Related]
6. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
Li D; Wang H; Ding Y; Zhang Z; Zheng Z; Dong J; Kim H; Meng X; Zhou Q; Zhou J; Fang L; Shen Q
Cancer Lett; 2018 Jun; 424():97-108. PubMed ID: 29580806
[TBL] [Abstract][Full Text] [Related]
7. Involvement of RhoA, ROCK I and myosin II in inverted orientation of epithelial polarity.
Yu W; Shewan AM; Brakeman P; Eastburn DJ; Datta A; Bryant DM; Fan QW; Weiss WA; Zegers MM; Mostov KE
EMBO Rep; 2008 Sep; 9(9):923-9. PubMed ID: 18660750
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer.
Hinsenkamp I; Schulz S; Roscher M; Suhr AM; Meyer B; Munteanu B; Fuchser J; Schoenberg SO; Ebert MP; Wängler B; Hopf C; Burgermeister E
Neoplasia; 2016 Aug; 18(8):500-11. PubMed ID: 27566106
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid stimulates cell adhesion through a novel p38 MAPK-RhoA signaling pathway that involves heat shock protein 27.
Garcia MC; Ray DM; Lackford B; Rubino M; Olden K; Roberts JD
J Biol Chem; 2009 Jul; 284(31):20936-45. PubMed ID: 19506078
[TBL] [Abstract][Full Text] [Related]
10. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
11. Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.
Orgaz JL; Crosas-Molist E; Sadok A; Perdrix-Rosell A; Maiques O; Rodriguez-Hernandez I; Monger J; Mele S; Georgouli M; Bridgeman V; Karagiannis P; Lee R; Pandya P; Boehme L; Wallberg F; Tape C; Karagiannis SN; Malanchi I; Sanz-Moreno V
Cancer Cell; 2020 Jan; 37(1):85-103.e9. PubMed ID: 31935375
[TBL] [Abstract][Full Text] [Related]
12. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
13. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
14. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
[TBL] [Abstract][Full Text] [Related]
15. SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II.
Choi DS; Stark DJ; Raphael RM; Wen J; Su J; Zhou X; Chang CC; Zu Y
Int J Cancer; 2015 Mar; 136(5):E219-29. PubMed ID: 25137150
[TBL] [Abstract][Full Text] [Related]
16. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
17. Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration.
Fife CM; Sagnella SM; Teo WS; Po'uha ST; Byrne FL; Yeap YY; Ng DC; Davis TP; McCarroll JA; Kavallaris M
Oncogene; 2017 Jan; 36(4):501-511. PubMed ID: 27321182
[TBL] [Abstract][Full Text] [Related]
18. FKBP51 regulates cell motility and invasion via RhoA signaling.
Takaoka M; Ito S; Miki Y; Nakanishi A
Cancer Sci; 2017 Mar; 108(3):380-389. PubMed ID: 28032931
[TBL] [Abstract][Full Text] [Related]
19. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
Liu X; Chen D; Liu J; Chu Z; Liu D
Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
[TBL] [Abstract][Full Text] [Related]
20. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
